Barclays’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,000
| Closed | -$4K | – | 4221 |
|
|
2024
Q1 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 4072 |
|
|
2023
Q4 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 4111 |
|
|
2023
Q3 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 4176 |
|
|
2023
Q2 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 4140 |
|
|
2023
Q1 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 4173 |
|
|
2022
Q4 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 4226 |
|
|
2022
Q3 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 4402 |
|
|
2022
Q2 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 4472 |
|
|
2022
Q1 | $6K | Buy |
+1,000
| New | +$6K | ﹤0.01% | 4557 |
|